This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Kyoto University. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Akihide Takeuchi: Innovator in Alternative Splicing Research
Introduction
Akihide Takeuchi is a prominent inventor based in Kyoto, Japan. He has made significant contributions to the field of molecular biology, particularly in understanding alternative splicing in mammalian organisms. His innovative work has implications for genetic research and therapeutic development.
Latest Patents
Akihide Takeuchi holds a patent for a "Transgenic reporter system that reveals expression profiles and regulation mechanisms of alternative splicing in mammalian organisms." This invention aims to develop a new alternative splicing reporter system. It provides a method for detecting alternative splicing patterns in a mammalian multicellular organism more precisely. The system also identifies substances and gene regions that affect alternative splicing, utilizing a DNA construct with at least two different reporter genes inserted into a specific gene undergoing alternative splicing.
Career Highlights
Takeuchi is affiliated with Kyoto University, where he conducts his research and development activities. His work has garnered attention for its innovative approach to studying gene expression and regulation mechanisms. He has been instrumental in advancing the understanding of alternative splicing, which is crucial for various biological processes.
Collaborations
One of his notable collaborators is Masatoshi Hagiwara. Together, they have worked on projects that enhance the understanding of genetic mechanisms and their implications in health and disease.
Conclusion
Akihide Takeuchi's contributions to the field of alternative splicing research highlight his role as an innovator in molecular biology. His patent and ongoing research efforts continue to pave the way for advancements in genetic understanding and therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
